We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Diagnostic Accuracy of Protein/Creatinine Ratio Influenced by Urine Concentration

By LabMedica International staff writers
Posted on 29 Sep 2015
Print article
The Clinitek Atlas Automated Urine Chemistry Analyzer
The Clinitek Atlas Automated Urine Chemistry Analyzer (Photo courtesy of Siemens Healthineers - Laboratory Diagnostics)
The diagnosis and management of proteinuric renal diseases and the staging of chronic kidney disease (CKD) require accurate identification and quantitation of proteinuria.

The usage of urine protein/creatinine ratio to estimate daily urine protein excretion is prevalent, but relatively little attention has been paid to the influence of urine concentration and its impact on test accuracy.

Scientists at the Taipei Veterans General Hospital (Taiwan) and their colleagues collected 540 urine samples with complete data of 24 hour urine protein concentration, creatinine concentration, total volume, and most importantly, a concomitant urinalysis of the same urine sample. After the total volume of the 24 hour urine sample had been measured and the storage container had been gently shaken for 10 seconds to mix the urine, two 10 mL specimens were sent for urinalysis and urine protein creatinine concentration measurement, respectively.

The urine protein and creatinine concentration of 24 hour and spot urine were both determined by the Hitachi 7180 Autoanalyzer (Hitachi; Tokyo, Japan). The specific gravity of the urinalysis was analyzed by using the Clinitek Atlas Automated Urine Chemistry Analyzer (Siemens Healthcare Diagnostics; Erlangen, Germany). In order to a compare distribution patterns of urine creatinine concentration between 24 hour and spot urine samples, a concurrent database of single voided urine samples collected during June 2010 to May 2014 were examined. Spot urine samples were collected at any time point of the day. There were 31,551 urine protein/creatinine ratio (UPCR) spot samples with a concomitant urinalysis examination.

The investigators found that found that for dilute urine samples with specific gravity equal to or less than 1.005, a sample with urine creatinine equal to or less than 38.8 mg/dL was more likely to overestimate actual daily urine protein excretion by using UPCR. For urine samples with specific gravity equal to or greater than 1.015, equal to or greater than 1.020, and equal to or greater than 1.025, those with urine creatinine concentration equal to or greater than 63.6 mg/dL, equal to or greater than 62.1 mg/dL, equal to or greater than 61.5 mg/dL, respectively, were more likely to lead to an underestimation.

The authors concluded that the UPCR in samples with low or high specific gravity is more likely to overestimate or underestimate actual daily urine protein amount, respectively, especially in a dilute urine sample with its creatinine below 38.8 mg/dL or a concentrated sample with its creatinine above 61.5 mg/dL. In particular, UPCR results should be interpreted with caution in cases that involve dilute urine samples because its overestimation may lead to an erroneous diagnosis of proteinuric renal disease or an incorrect staging of chronic kidney disease. The study was published on September 9, 2015, in the journal PLOS ONE.

Related Links:

Taipei Veterans General Hospital
Hitachi
Siemens Healthcare Diagnostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.